Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Editorial Boards
    • Contact Us
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Editorial Boards
    • Contact Us
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Resident & Fellow Section

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
American Academy of Neurology Journals
Home
  • Subscribe
  • My Alerts
  • Log in
Site Logo

Innovations in Care Delivery

Editors' Blog

  • Aducanumab: Making Sense of the Cents
    Gregory S. Day, MD, MSc, MSCI, FAAN | April 7, 2022


    More than 6 million Americans are living with symptomatic Alzheimer disease (AD). When spouses, children, other family members, and friends are included, the staggering burden of this disease is readily apparent. The cost of caring for patients with AD is similarly immense. Whether measured in dollars, hours of care, quality life years lost, or pressures on the gross domestic product, AD is one of the costliest diseases of our time. Understandably, therefore, patients, families, practitioners, insurers, governments, and drug manufacturers are all clamoring for effective disease-modifying therapies.

    [Continued]


    Aducanumab Resource Site


    The US Food and Drug Administration (FDA) announced on June 7, 2021, the approval of aducanumab (Aduhelm). The drug was approved under the Accelerated Approval pathway, one of the alternative drug approval pathways.

    In addition to our latest articles on cognitive disorders and dementia, Neurology has included a list of aducanumab resources to help our members stay informed on the current landscape of the new Alzheimer disease drug.

    Find out more


    The Effect of COVID-19 on Neurologic Practice

     

    The COVID-19 pandemic is affecting neurologic care across the globe. We plan to highlight blogs from neurologists on their experiences, particularly in regards to innovations in care delivery that have resulted from this pandemic.
     

    Is pediatric epilepsy surgery elective? Considerations in the era of COVID-19

    Erin Fedak Romanowski, DO     Read full article
    Assistant Professor, Department of Pediatrics, Division of Pediatric Neurology, CS Mott Children’s Hospital, Michigan Medicine, Ann Arbor
    Nancy McNamara, MD
    Assistant Professor, Department of Pediatrics, Division of Pediatric Neurology, CS Mott Children’s Hospital, Michigan Medicine, Ann Arbor


    Together, apart: Effective communication in inpatient neurology during COVID-19

    Tarini Goyal, MD     Read full article
    Department of Neurology & Neurological Sciences, Neurohospitalist Program, Stanford University School of Medicine, Palo Alto, CA

    View Blog Site
  • Editors' Top Five Recommended Reading

    Geographic Variation in Neurologist Density and Neurologic Care in the United States

    Chun Chieh Lin, Brian C. Callaghan, James F. Burke, Lesli E. Skolarus, Chloe E. Hill, Brandon Magliocco, Gregory J. Esper, Kevin A. Kerber

     

    Increasing Out-of-Pocket Costs for Neurologic Care for Privately-Insured Patients

    Chloe E. Hill, Evan L. Reynolds, James F. Burke, Mousumi Banerjee, Kevin A. Kerber, Brandon Magliocco, Gregory J. Esper, Lesli E. Skolarus, Brian C. Callaghan

     

    Quality and Safety Analysis of 2999 Telemedicine Encounters During the COVID-19 Pandemic

    Charuta N Joshi, Michele L Yang, Krista Eschbach, Suhong Tong, Mona P Jacobson, Chelsey Stillman, Annmarie E Kropp, Stephanie A Shea, Gerard M Frunzi, J Fred Thomas, Christina A Olson

     

    A Bronx Tale: Disparities in Access to Neurologic Telemedicine During the COVID-19 Pandemic

    Jonathan M. Gursky, Alex Boro, Sheri Escalante, Victor Ferastraoaru, Rajani Hanumanthu, Sheryl Haut, Rana Jehle, Isaac Molinero, Lindsay Rick, Jillian Rosengard, Mohammad Saifeddine, William Sugrue, Solomon L. Moshé, Karen Ballaban-Gil

     

    Prehospital Midazolam Use and Outcomes Among Patients With Out-of-Hospital Status Epilepticus

    Elan L. Guterman, Joseph K. Sanford, John P. Betjemann, Li Zhang, James F. Burke, Daniel H. Lowenstein, S. Andrew Josephson, Karl A. Sporer

     

     

     

Latest Articles

  • Editorial
    Contextualizing Adverse Childhood Experiences in Patients With Parkinson DiseaseThe Beginnings of a Complicated Area of Neurologic Research
    Adys Mendizabal
    Neurology: Clinical Practice March 22, 2023
  • Research Article
    Hospital EEG Capability and Associations With Interhospital Transfer in Status Epilepticus
    Catherine G. Suen, Andrew J. Wood, James F. Burke, et al.
    Neurology: Clinical Practice March 16, 2023
  • Research Article
    Inequities in Telemedicine Use Among Patients With Stroke and Cerebrovascular DiseasesA Tricenter Cross-sectional Study
    Imama A. Naqvi, Audrey S. Cohen, Youngran Kim, et al.
    Neurology: Clinical Practice March 14, 2023
  • Editorial
    Looming Crisis of Financial Toxicity in Neurologic Drug PricingFrom Out-of-Pocket to Out-of-Community Costs
    A. Gordon Smith
    Neurology November 30, 2022
Show more
  • Browse Subcategories

    • All Health Services Research
    • Cost Effectiveness/Economic
    • Decision Analysis
    • Diagnostic Test Assessment
    • Harm/Risk Analysis
    • Medical Care
    • Outcome Research
    • Patient Safety
    • Quality of Life
  • Interview With A Health Services Expert

    Dr. Kevin Kerber interviews Dr. Ralph Sacco  

    Dr. Sacco talks about his leadership role in balancing the needs of neurologists, the department and other stake holders with the needs of patients. He outlines successful approaches to improving patient access to quality care, the challenges in implementing these approaches, and what he sees as the future in care delivery.

    In April of 2017, Drs. Kerber and Callaghan had the chance to talk to Ralph L. Sacco, MD, MS, University of Miami Miller School of Medicine where Dr. Sacco is  Chairman & Professor Department of Neurology, Director and Principal Investigator of the University of Miami Clinical and Translational Science Institute, Executive Director Evelyn F McKnight Brain Institute, Miller Professor of Epidemiology, Public Health Sciences, Human Genetics, and Neurosurgery, Olemberg Family Chair in Neurological Disorders and Senior Associate Dean for Clinical & Translational Science. Dr. Sacco is also the President of the American Academy of Neurology.

    Sacco image

    N A M E: Ralph L. Sacco, MD, MS, FAHA, FAAN
    T I T L E: Chairman & Professor Department of Neurology; Director and  Principal Investigator of the University of Miami Clinical and Translational Science Institute; Executive Director Evelyn F McKnight Brain Institute; Miller Professor of Epidemiology, Public Health Sciences, Human Genetics, and Neurosurgery; Olemberg Family Chair in Neurological Disorders; and Senior Associate Dean for Clinical & Translational Science.
    E D U C A T I O N: Dr. Sacco is a graduate of Cornell University and graduated cum laude from Boston University School of Medicine. He holds a master’s in epidemiology from Columbia University, School of Public Health and completed his residency training and postdoctoral training in stroke and epidemiology at New York’s Columbia Presbyterian.
    H O B B I E S: Renovating homes in NY, biking, and volunteer work.

    INTERVIEW Audio

    FUll transcript of interview


     A  R  C  H  I  V  E  S 

Podcasts

  • Dr. Kevin Kerber interviews Dr. Ralph Sacco
    January 1, 2018
    Listen22:37
    IICD image
    View All Podcasts
Advertisement
  • Call to Action!

    ​An important perspective about new medical equipment in low resource countries: Dr. Omar Siddiqi, Assistant Professor of Neurology at Harvard Medical School and the Director of the Global Neurology Program at Beth Israel Deaconess Medical Center, shares his experiences with the unforeseen negatives to innovative, medical technology in resource limited settings. He states, "Near as I can tell, the only purpose they serve is to charge patients for a sham test."

  • About The Editors

    Callaghan Image

    Editor, Innovations in Care Delivery
    Brian C. Callaghan, MD, MS
    Ann Arbor, MI

    Biography

     

    Kerber image

    Editor, Innovations in Care Delivery
    Kevin A. Kerber, MD, MS
    Ann Arbor MI

    Biography

  • RESOURCES
     
    • AAN Resources/Practice
    • Alternative Payment Models
    • MACRA
    • AAN Resources/Academic
    • Agency for Healthcare Research
    • The Centers for Medicare & Medicaid Services
    • Health Affairs
    • Health Affairs - Top Ten Most-Read Articles in Health Services Research
    • Patient-Centered Outcomes Research Institute
    • Rock Health
  • Neurology Podcast - Over 16 million downloads!
    Neurology Podcast
    Links Between Pain & Depression with Unemployment Due to CNS Cancer
    Dr. Stacey Clardy and Dr. Heather Leeper discuss the social ramifications of a neurological diagnosis and the importance of palliative care. March 28, 2023
    Neurology, Journal, Podcast
    Listen15:38
    Subscribe
    View Recent Podcasts
Site Logo
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise